Position in VTGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$51,099
+$6,027 QoQ
Shares Held
89,649
+297.8% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SIMPLEX TRADING, LLC holds $69,665,443 across 197 Biotechnology names. VTGN ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
219,573 | $11,154,308 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
77,808 | $6,549,099 | |
| 3 | ERAS |
Erasca, Inc.
|
252,747 | $4,089,446 | |
| 4 | QURE |
uniQure N.V.
|
231,769 | $3,789,423 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
41,434 | $3,076,888 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
69,515 | $2,802,149 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
88,035 | $2,438,569 | |
| 8 | INSM |
INSMED Inc
|
10,715 | $1,752,116 |
All Filings in VTGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $51,099 | 89,649 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $45,072 | 22,536 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $6,005 | 2,402 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,649 | 2,593 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $69,230 | 23,000 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $59,532 | 17,107 | Shares | Sole | 2024-07-25 | |
| 2023-12-31 | $63,586 | 12,371 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $12,911 | 2,464 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,769 | 946 | Shares | Sole | 2023-08-04 | |
| No filing history on record for this holder in this stock. | ||||||